| 101 |
NCT01643720 |
Completed |
Emotion Regulation in Preschoolers With Autism and Their Parents |
- Autism Spectrum Disorders
|
|
Observational |
|
|
Other |
- Observational Model: Case Control
- Time Perspective: Prospective
|
- Emotion regulation(ER)strategies during emotion eliciting episodes
- Salivary hormone levels: Cortisol and Oxytocin of both parent and child
|
80 |
All |
3 Years to 6 Years (Child) |
NCT01643720 |
MMC1013010kCTIL |
|
November 2010 |
May 2011 |
May 2011 |
July 18, 2012 |
April 8, 2015 |
|
- Brill Mental Health Center
Tel Aviv, Israel
|
| 102 |
NCT02184390 |
Completed |
Parenting Your Young Child With Autism: A Web-Based Tutorial |
|
- Other: On LIne Parent Training Tutorial
|
Interventional |
Not Applicable |
- Center for Psychological Consultation
- National Institute of Mental Health (NIMH)
|
Other / NIH |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Prevention
|
- System Usability Scale
- Autism Knowledge Test
|
104 |
All |
18 Months to 6 Years (Child) |
NCT02184390 |
5R44MH086936 |
|
May 2013 |
May 2015 |
September 2015 |
July 9, 2014 |
February 3, 2016 |
|
- Center for Psychological Consulation
Madison, Wisconsin, United States
|
| 103 |
NCT01836562 |
Unknown † |
A Clinical Trial to Study the Safety and Efficacy of Bone Marrow Derived Autologous Cells for the Treatment of Autism |
|
- Biological: STEM CELL THERAPY
|
Interventional |
Phase 1
Phase 2 |
|
Other |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Improvement in childhood autism rating scale
- Improvement in perfusion of brain with PET scan report
|
100 |
All |
3 Years to 70 Years (Child, Adult, Senior) |
NCT01836562 |
00105 |
BMCA |
September 2014 |
June 2016 |
June 2016 |
April 22, 2013 |
September 17, 2014 |
|
- Chaitanya Hospital
Pune, Maharashtra, India
|
| 104 |
NCT02695693 |
Active, not recruiting |
RCT of TeachTown in Autism Support Classrooms: Innovation and Exnovation |
|
- Behavioral: TeachTown
- Behavioral: Discrete Trial Training
- Behavioral: Pivotal Response Training
- Behavioral: Teaching in Functional Routines
|
Interventional |
Not Applicable |
- University of Pennsylvania
- National Institute of Mental Health (NIMH)
- School District of Philadelphia
|
Other / NIH |
- Allocation: Randomized
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Differential Abilities Scale, 2nd Edition
- Bracken School Readiness Assessment, 3rd Edition
|
212 |
All |
5 Years to 9 Years (Child) |
NCT02695693 |
R01MH106175 |
|
April 2015 |
June 2017 |
March 2019 |
March 1, 2016 |
August 9, 2017 |
|
|
| 105 |
NCT01881750 |
Unknown † |
Pivotal Response Group Treatment for Parents of Young Children With Autism |
|
- Behavioral: Pivotal Response Training
- Behavioral: Parent Education Group
|
Interventional |
Not Applicable |
- Stanford University
- Autism Speaks
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Change from Baseline in communication during parent-child and clinician-child interactions at 6, 12, and 24 weeks
- Parenting Stress Index
- Family Empowerment Scale
- (and 4 more...)
|
50 |
All |
2 Years to 6 Years (Child) |
NCT01881750 |
SU-11022010-7151 |
|
September 2010 |
September 2013 |
September 2013 |
June 20, 2013 |
June 20, 2013 |
|
- Stanford University School of Medicine
Stanford, California, United States
|
| 106 |
NCT02708069 |
Completed |
e-Unstuck:Interactive e-Learning Software for Parents to Support Executive Functioning and Behavior Regulation in Children With Autism Spectrum Disorder |
|
- Other: e-Unstuck
- Other: Unstuck and On Target
|
Interventional |
Not Applicable |
- 3-C Institute for Social Development
- Children's National Health System
|
Industry / Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Supportive Care
|
- Change from baseline in parental knowledge of executive function and the Unstuck and On Target (UOT) intervention as measured on the UOT Knowledge Questionnaire.
- Change from baseline in parental stress on the Parenting Stress Index, Fourth Edition, Short Form (PSI-4-SF).
- Change from baseline in parental self-efficacy on the Parenting Sense of Competence Scale.
- Change from baseline in child executive function as measured on the Behavior Rating of Executive Function (BRIEF)
|
97 |
All |
Child, Adult, Senior |
NCT02708069 |
1R44MH109193 |
e-Unstuck |
March 1, 2017 |
February 28, 2018 |
February 28, 2018 |
March 15, 2016 |
March 2, 2018 |
|
- Children's National Health System
Rockville, Maryland, United States - 3C Institute
Durham, North Carolina, United States
|
| 107 |
NCT02275455 |
Recruiting |
Design Of WELL Being Monitoring Systems, Application in Autism |
|
- Behavioral: real life situations
|
Interventional |
Not Applicable |
- University Hospital, Clermont-Ferrand
|
Other |
- Allocation: Non-Randomized
- Intervention Model: Parallel Assignment
- Masking: Double (Investigator, Outcomes Assessor)
- Primary Purpose: Prevention
|
- Heart Rate Variability from holter electrocardiogram
- Heart Rate Variability from the heart rate transmitter belt
|
60 |
All |
12 Years to 25 Years (Child, Adult) |
NCT02275455 |
CHU-0213
2014-A00611-46 |
Do Well B |
October 2014 |
December 2016 |
December 2018 |
October 27, 2014 |
July 26, 2016 |
|
- University Hospital of Clermont-Ferrand (CHU), France
Clermont-Ferrand, France
|
| 108 |
NCT02477904 |
Active, not recruiting |
Ketogenic Diet Therapy for Autism Spectrum Disorder |
|
|
Interventional |
Not Applicable |
- Shriners Hospitals for Children
- University of Hawaii
|
Other |
- Allocation: Non-Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Change from baseline in core symptoms of ASD
- Change from baseline in the number of medications used for ASD management
- Change from baseline in the dosage of medications used for ASD management
- (and 4 more...)
|
119 |
All |
2 Years to 21 Years (Child, Adult) |
NCT02477904 |
HON1403 |
|
March 2015 |
February 2018 |
February 2018 |
June 23, 2015 |
January 30, 2018 |
|
- Shriners Hospitals for Children - Honolulu
Honolulu, Hawaii, United States
|
| 109 |
NCT02998684 |
Active, not recruiting |
Learning Enhancement Through Neurostimulation in Autism |
|
- Device: Active Transcranial Direct Current Stimulation
- Device: Sham Transcranial Direct Current Stimulation
- Behavioral: PEERS Social Skills Training
|
Interventional |
Not Applicable |
- Medical University of South Carolina
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
|
Other / NIH |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Triple (Participant, Care Provider, Investigator)
- Primary Purpose: Treatment
|
- Test of Adolescent Social Skills Knowledge (TASSK)
- Social Responsiveness Scale (SRS)
- Percent signal change in regions of interest
|
25 |
All |
14 Years to 17 Years (Child) |
NCT02998684 |
Pro00056912 |
LENS |
July 2016 |
July 2017 |
July 2017 |
December 20, 2016 |
July 2, 2017 |
|
- Medical Univeristy of South Carolina
Charleston, South Carolina, United States
|
| 110 |
NCT01366885 |
Completed
Has Results |
Vitamin D to Prevent Autism in Newborn Siblings |
|
|
Interventional |
Phase 2 |
- Oregon Health and Science University
|
Other |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Prevention
|
- Number of Children Who Developed Autism
- Number of Mothers Who Developed Side Effects From Vitamin D
|
20 |
Female |
20 Years to 44 Years (Adult) |
NCT01366885 |
OHSU-AS-11-1-11 |
|
February 2008 |
February 2016 |
February 2016 |
June 6, 2011 |
June 14, 2016 |
June 14, 2016 |
- Evergreen Center
Oregon City, Oregon, United States
|
| 111 |
NCT02646696 |
Completed |
Reliability Study Using Electrodermal Activity to Measure Sensory Processing in Children With and Without Autism Spectrum Disorder |
|
- Other: Sensory Challenge Protocol
|
Observational |
|
- Barpak Geriatric Health Services, Inc. d/b/a Barpak Occupational Therapy
|
Other |
- Observational Model: Case Control
- Time Perspective: Prospective
|
- Electrodermal Activity in response to sensation
|
32 |
Male |
4 Years to 11 Years (Child) |
NCT02646696 |
Barpak-01-EDA |
|
January 2013 |
April 2014 |
May 2014 |
January 6, 2016 |
January 6, 2016 |
|
|
| 112 |
NCT01813318 |
Recruiting |
Study of Acamprosate in Autism |
|
- Drug: Acamprosate
- Drug: Placebo
|
Interventional |
Phase 2
Phase 3 |
- Children's Hospital Medical Center, Cincinnati
- Autism Speaks
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- Change from baseline to week 10 on the Social WIthdrawal subscale of ABC
- Change Clinical Global Impression- Improvement
- Change in ABC subscales: Irritability, Stereotypy, Hyperactivity, and Inappropriate Speech from baseline to week 10
|
36 |
All |
5 Years to 17 Years (Child) |
NCT01813318 |
CIN001-Acamprosate in Autism |
|
April 2013 |
February 2018 |
February 2018 |
March 18, 2013 |
July 21, 2017 |
|
- Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, United States
|
| 113 |
NCT02037022 |
Completed |
Pivotal Response Treatment Package for Young Children With Autism |
- Autism Spectrum Disorder (ASD)
- Autism
|
- Behavioral: Pivotal Response Treatment Package (PRT-P)
|
Interventional |
Not Applicable |
- Stanford University
- National Institute on Deafness and Other Communication Disorders (NIDCD)
|
Other / NIH |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Change from Baseline in communication during parent-child and clinician-child interactions at 6, 12, and 24 weeks
- Change from Baseline on the Preschool Language Scale, 5th Edition (PLS-5) at 12, and 24 weeks
- Change from Baseline on the Sensory Profile Questionnaire at 6, 12, and 24 weeks
- (and 8 more...)
|
48 |
All |
2 Years to 5 Years (Child) |
NCT02037022 |
IRB-28314
R21DC013689 |
PRT-P |
November 2013 |
July 28, 2017 |
July 28, 2017 |
January 15, 2014 |
January 26, 2018 |
|
- Stanford University School of Medicine
Stanford, California, United States
|
| 114 |
NCT02874690 |
Recruiting |
Stimulant Autism Test |
- Autism Spectrum Disorder
- Attention Deficit Hyperactivity Disorder
|
- Drug: Methylphenidate
- Drug: Placebo
|
Interventional |
Phase 2 |
- Children's Hospital Medical Center, Cincinnati
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- Change in Eye-Tracking: Microsaccades and pupil size using Tobii eye tracker
- Change in Short Interval IntraCortical Inhibition (SICI) using Transcranial Magnetic Stimulation (TMS)
- Change in Resting State Electroencephalogram (EEG)
|
60 |
All |
8 Years to 21 Years (Child, Adult) |
NCT02874690 |
2015-4401 |
SAT |
February 2016 |
October 2018 |
|
August 22, 2016 |
August 25, 2016 |
|
- Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, United States
|
| 115 |
NCT03361787 |
Recruiting |
A Multi-dimensional Program for Parents of Adolescents With High-functioning Autism |
|
- Behavioral: "Parentship"- a multi dimensional intervention program to improve parental resilience
|
Interventional |
Not Applicable |
- Hadassah Medical Organization
- Hebrew University of Jerusalem
|
Other |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Canadian Occupational Performance Measure (COPM)
- Autism: Parenting Questionnaire (APQ)
- Clinical Assessment of Therapeutic Responses (CATR)
|
15 |
All |
13 Years to 18 Years (Child, Adult) |
NCT03361787 |
0269-17-HMO-CTIL |
|
January 15, 2018 |
May 14, 2019 |
December 14, 2019 |
December 5, 2017 |
February 22, 2018 |
|
- Hadassah medical organization, Jerusalem Israel
Jerusalem, Israel
|
| 116 |
NCT01944046 |
Completed |
Study of Oxytocin in Autism to Improve Reciprocal Social Behaviors |
- Autism Spectrum Disorders
|
- Drug: Placebo Nasal Spray
- Drug: Oxytocin Nasal Spray
|
Interventional |
Phase 2 |
- Linmarie Sikich
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- Duke University
|
Other / NIH |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- Change in ABC-SW subscale--Reciprocal Social Behavior
- Change in SRS-Social Motivation Subscale
- Change in Stanford Binet-5th Edition (SB-5)/Mullen
- (and 3 more...)
|
290 |
All |
3 Years to 17 Years (Child) |
NCT01944046 |
Pro00063950
1U01HD073984
13-0593 |
SOARS-B |
August 2014 |
November 30, 2017 |
November 30, 2017 |
September 17, 2013 |
January 23, 2018 |
|
- Lurie Center for Autism, Massachusetts General Hospital
Boston, Massachusetts, United States - Mount Sinai School of Medicine
New York, New York, United States - Center for Autism and the Developing Brain
White Plains, New York, United States - (and 4 more...)
|
| 117 |
NCT00760812 |
Completed |
Comparing Parent-Implemented Interventions for Toddlers With Autism Spectrum Disorders |
|
- Behavioral: Early Social Interaction Project- PII
- Behavioral: Early Social Interaction Project- IES
|
Interventional |
Not Applicable |
- Florida State University
- National Institute of Mental Health (NIMH)
|
Other / NIH |
- Allocation: Randomized
- Intervention Model: Crossover Assignment
- Masking: Single (Outcomes Assessor)
- Primary Purpose: Treatment
|
- Child measures of autism symptoms, social communication, developmental level, and adaptive behavior
- Parent report measures of family functioning, daily hassles, and treatment satisfaction
|
82 |
All |
16 Months to 20 Months (Child) |
NCT00760812 |
R01MH077730
1R01MH077730-01A2
1R01MH078165-01A2
DDTR B2-MBA |
|
April 2007 |
May 2013 |
January 2014 |
September 26, 2008 |
February 20, 2014 |
|
- Florida State University
Tallahassee, Florida, United States - University of Michigan
Ann Arbor, Michigan, United States
|
| 118 |
NCT01921244 |
Completed |
Shared Decision Making to Improve Care and Outcomes for Children With Autism |
- Autistic Disorder
- Pervasive Developmental Disorder
- Child Development Disorders, Pervasive
- (and 3 more...)
|
|
Interventional |
Not Applicable |
- Children's Hospital Medical Center, Cincinnati
|
Other |
- Allocation: Randomized
- Intervention Model: Crossover Assignment
- Masking: Single (Outcomes Assessor)
- Primary Purpose: Health Services Research
|
- Decisional Conflict
- Parent-physician interaction
|
142 |
All |
4 Years to 15 Years (Child) |
NCT01921244 |
FP00005038 |
|
August 2013 |
July 2015 |
July 2015 |
August 13, 2013 |
February 5, 2016 |
|
- Cincinnati Children's Medical Center
Cincinnati, Ohio, United States
|
| 119 |
NCT02611921 |
Recruiting |
Study of Intranasal Ketamine for Social Impairment in Autism Spectrum Disorder |
|
- Drug: Ketamine
- Drug: Placebo
|
Interventional |
Phase 1 |
- Children's Hospital Medical Center, Cincinnati
- Roivant Sciences, Inc.
- Cures Within Reach
|
Other / Industry |
- Allocation: Randomized
- Intervention Model: Crossover Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- Change in Social Withdrawal subscale score of the Aberrant Behavior Checklist (ABC)
- Change in the Clinician-rated CGI Improvement scale (CGI-I)
|
24 |
All |
12 Years to 30 Years (Child, Adult) |
NCT02611921 |
2015-2494 |
|
December 2015 |
May 2018 |
December 2018 |
November 23, 2015 |
August 30, 2017 |
|
- Cincinnati Childrens Hospital Medical Center
Cincinnati, Ohio, United States
|
| 120 |
NCT00252603 |
Completed |
Galantamine Versus Placebo in Childhood Autism |
|
|
Interventional |
Phase 3 |
- University of Medicine and Dentistry of New Jersey
- National Alliance for Autism Research
- Rutgers, The State University of New Jersey
|
Other |
- Allocation: Randomized
- Intervention Model: Single Group Assignment
- Masking: Double
- Primary Purpose: Treatment
|
- Autism Diagnostic Observation Schedule-Generic (ADOS-G)- Change from Baseline to Final Visit
- Clinical Global Impression Improvement (CGI)- Change from Baseline to Final Visit
- Aberrant Behavior Checklist (ABC) (hyperactivity/irritability sections)- Change from Baseline to Final Visit
- (and 3 more...)
|
20 |
All |
5 Years to 17 Years (Child) |
NCT00252603 |
4682 |
|
April 2004 |
|
April 2007 |
November 11, 2005 |
January 29, 2007 |
|
- UMDNJ Robert Wood Johnson Medical School - Dept of Psychiatry
Piscataway, New Jersey, United States
|
| 121 |
NCT03204786 |
Recruiting |
Intranasal Vasopressin Treatment in Children With Autism |
- Autism
- Autism Spectrum Disorder
- ASD
|
- Drug: Vasopressin (USP) Injectable Solution [Vasostrict]
- Drug: Placebo
|
Interventional |
Phase 2 |
- Stanford University
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
|
Other / NIH |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Change from baseline in parent rated Social Responsiveness Scale, Second Edition (SRS-2) total scores during treatment.
- Change from baseline in Clinical Global Impression (CGI) scores during treatment.
- Change from baseline in Vineland Adaptive Behavior Scales, Third Edition (VABS-3) - Social Skills and Relationships Domain during treatment.
- (and 15 more...)
|
100 |
All |
6 Years to 17 Years (Child) |
NCT03204786 |
IRB-39972
1R01HD091972 |
|
February 20, 2018 |
December 2022 |
February 2023 |
July 2, 2017 |
February 26, 2018 |
|
- Stanford University
Stanford, California, United States
|
| 122 |
NCT00498173 |
Completed
Has Results |
Effectiveness of Atomoxetine in Treating ADHD Symptoms in Children and Adolescents With Autism |
|
- Drug: Atomoxetine
- Drug: Placebo
|
Interventional |
Phase 3 |
- Massachusetts General Hospital
- National Institute of Mental Health (NIMH)
|
Other / NIH |
- Allocation: Randomized
- Intervention Model: Sequential Assignment
- Masking: Triple (Participant, Care Provider, Investigator)
- Primary Purpose: Treatment
|
- ADHD Rating Scale (ADHDRS)-Home Version Total Score (Randomized Phase)
- ADHD Rating Scale (ADHDRS)-Home Version Inattention and Hyperactivity Scores (Randomized Phase)
- Aberrant Behavior Checklist (ABC) (Randomized Phase)
- (and 12 more...)
|
60 |
All |
5 Years to 15 Years (Child) |
NCT00498173 |
R01MH077600
DDTR B2-NDA |
|
July 2007 |
October 2015 |
October 2015 |
July 9, 2007 |
August 14, 2017 |
August 14, 2017 |
- Christian Sarkine Autism Treatment Center at Riley Hospital for Children
Indianapolis, Indiana, United States - Lurie Center - MassGeneral Hospital
Lexington, Massachusetts, United States
|
| 123 |
NCT01727466 |
Completed |
Treatment for Children With Autism and Anxiety |
|
- Behavioral: Facing Your Fears
|
Interventional |
Not Applicable |
- University of Colorado, Denver
- Autism Speaks
|
Other |
- Intervention Model: Single Group Assignment
- Masking: Single (Outcomes Assessor)
- Primary Purpose: Treatment
|
- Change in Clinical Global Impression Scale - Improvement and Severity (CGIS-S; CGIS-I)
- Anxiety Disorders Interview Survey for Children-Parent Version (ADIS-P)
|
50 |
All |
8 Years to 14 Years (Child) |
NCT01727466 |
03-0245 |
|
August 2006 |
September 2009 |
December 2009 |
November 16, 2012 |
November 16, 2012 |
|
|
| 124 |
NCT03033784 |
Recruiting |
Autism Oxytocin Brain Project |
- Autism
- Autism Spectrum Disorder
|
- Drug: Oxytocin
- Drug: Placebo
|
Interventional |
Phase 2 |
- Emory University
- National Institute of Mental Health (NIMH)
|
Other / NIH |
- Allocation: Randomized
- Intervention Model: Crossover Assignment
- Masking: Double (Participant, Investigator)
- Primary Purpose: Treatment
|
- Difference in Resting State Functional Connectivity (rsFC)
- Difference in Blood Oxygen Level Dependent (BOLD) Activity in Response to Social Cues
- Difference in Blood Oxygen Level Dependent (BOLD) Activity in Response to Dynamic Social Cues
- (and 5 more...)
|
80 |
Male |
18 Years to 45 Years (Adult) |
NCT03033784 |
IRB00093455
P50MH100023 |
|
May 10, 2017 |
April 30, 2018 |
March 30, 2019 |
January 27, 2017 |
March 26, 2018 |
|
- Emory University
Atlanta, Georgia, United States
|
| 125 |
NCT02712853 |
Recruiting |
Improving Autism Screening With Brain-Related miRNA |
- Autism Spectrum Disorder
- Developmental Delay
|
- Other: Saliva collection
- Other: Vineland Adaptive Behavior Scale-II Assessment
|
Observational |
|
- Milton S. Hershey Medical Center
|
Other |
- Observational Model: Case-Control
- Time Perspective: Cross-Sectional
|
- salivary miRNA profile
- Measures of adaptive function
- Measure of autistic behavior
|
300 |
All |
2 Years to 6 Years (Child) |
NCT02712853 |
Study00003658 |
|
November 2015 |
December 2018 |
December 2019 |
March 18, 2016 |
May 19, 2017 |
|
- Penn State Milton S. Hershey Medical Center
Hershey, Pennsylvania, United States
|
| 126 |
NCT03195465 |
Active, not recruiting |
The Effect of High Antioxidant Cacao on Behaviors in Children With Autism Spectrum Disorder |
|
- Dietary Supplement: Dark Chocolate
|
Interventional |
Not Applicable |
|
Other |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Supportive Care
|
- Aberrant Behavior Checklist
- Autism Spectrum Rating Scale
|
23 |
All |
5 Years to 18 Years (Child, Adult) |
NCT03195465 |
5170206 |
|
November 14, 2017 |
July 2018 |
July 2018 |
June 22, 2017 |
March 27, 2018 |
|
- Loma Linda University Health
Loma Linda, California, United States
|
| 127 |
NCT02423499 |
Recruiting |
Features Emotional Responses in Adults With Autism: Comparison With Bipolar Disorder (REMBAU) |
- Autism Spectrum Disorder
- Bipolar Disorder
|
|
Observational |
|
- University Hospital, Tours
|
Other |
- Observational Model: Cohort
- Time Perspective: Prospective
|
- Physiological emotional response during emotion elicitation in a laboratory session (Pupil size measured by eye tracking, heart rate, electrodermal response, breath rate) during emotion elicitation in a laboratory session
- Subjective emotional response during emotion elicitation in a laboratory session
- Facial emotional response during emotion elicitation in a laboratory session
- (and 2 more...)
|
90 |
All |
18 Years to 50 Years (Adult) |
NCT02423499 |
PHAO13-ML/REMBAU
2014-A00431-46 |
REMBAU |
May 19, 2015 |
May 2019 |
May 2019 |
April 22, 2015 |
November 1, 2017 |
|
|
| 128 |
NCT00695812 |
Unknown † |
The Development of Younger Siblings of Children With Autism Now at 10 Years of Age |
- Autism Spectrum Disorders
|
|
Observational |
|
- Shaare Zedek Medical Center
- Hebrew University of Jerusalem
|
Other |
- Observational Model: Cohort
- Time Perspective: Prospective
|
|
104 |
All |
10 Years to 11 Years (Child) |
NCT00695812 |
Siblings Autism.ctil |
|
September 2008 |
September 2011 |
September 2011 |
June 12, 2008 |
June 12, 2008 |
|
|
| 129 |
NCT02192749 |
Completed |
Allogeneic Umbilical Cord Mesenchymal Stem Cell Therapy for Autism |
|
- Biological: Umbilical cord mesenchymal stem cells
|
Interventional |
Phase 1
Phase 2 |
- Translational Biosciences
|
Industry |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Number of participants with adverse events
- Number of participants with a change in disability as measured by the Autism Treatment Evaluation Checklist (ATEC)
- Number of participants with a change in disability as measured by the Childhood Autism Rating Scale (CARS)
- (and 2 more...)
|
20 |
All |
6 Years to 16 Years (Child) |
NCT02192749 |
TBS-UCMSC-ASD001 |
|
July 2014 |
August 2017 |
August 2017 |
July 17, 2014 |
October 13, 2017 |
|
- Stem Cell Institute
Panama City, Panama
|
| 130 |
NCT03338530 |
Completed |
Efficacy of a Comprehensive School-based Intervention for High-functioning Children With Autism Spectrum Disorder |
|
- Behavioral: Comprehensive School-Based Intervention
|
Interventional |
Not Applicable |
- Canisius College
- U.S. Department of Education
|
Other / U.S. Fed |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Single (Outcomes Assessor)
- Primary Purpose: Treatment
|
- Change from Baseline Cambridge Mindreading Face-Voice Battery for Children (CAM-C) Scores at Follow-up
- Change from Baseline Social Responsiveness Scale, 2nd Edition, School Age Form (SRS-2) Scores at Follow-up
- Change from Baseline Adapted Skillstreaming Checklist (ASC) Scores at Follow-up
- (and 2 more...)
|
103 |
All |
6 Years to 12 Years (Child) |
NCT03338530 |
2012-13#142RENEWAL-Ammend |
|
August 1, 2013 |
July 31, 2017 |
July 31, 2017 |
November 9, 2017 |
November 9, 2017 |
|
|
| 131 |
NCT00917683 |
Terminated |
Investigation of Neuroserpin as an Autism Candidate Gene |
|
|
Observational |
|
- State University of New York - Upstate Medical University
|
Other |
- Observational Model: Case Control
- Time Perspective: Prospective
|
- Determine SERPIN1 gene sequence variation in autistic subjects.
|
5 |
All |
1 Year and older (Child, Adult, Senior) |
NCT00917683 |
IRB#5811 |
|
June 2009 |
April 2012 |
April 2012 |
June 10, 2009 |
April 19, 2016 |
|
- SUNY Upstate Medical University
Syracuse, New York, United States
|
| 132 |
NCT02493699 |
Completed |
Martial Arts Therapy in Autism Spectrum Disorders |
- Autism Spectrum Disorders
|
- Other: physical exercise- based intervention (Karate techniques training)
|
Interventional |
Not Applicable |
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Raw score of communication subscale of Gilliam Autism Rating Scale-Second Edition (GARS-2) as the measure of communication deficit
|
30 |
All |
5 Years to 16 Years (Child) |
NCT02493699 |
14/02/2011 |
|
May 2011 |
August 2011 |
September 2011 |
July 9, 2015 |
July 9, 2015 |
|
|
| 133 |
NCT02617342 |
Active, not recruiting |
Robot-Mediated Intervention for Children With Autism Spectrum Disorders |
|
- Behavioral: Robot-mediated Intervention
|
Interventional |
Not Applicable |
- Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
- Aetna, Inc.
|
Other / Industry |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Double (Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- Change in baseline emotions accurately identified on the Transporters Quiz
- Change in baseline Social Responsiveness Scale Score
- Number of prompt-free intervals during the treatment sessions
- Change in baseline parent report of child's emotion recognition
|
40 |
All |
4 Years to 8 Years (Child) |
NCT02617342 |
IRB00067744 |
|
November 2015 |
December 2018 |
December 2018 |
November 30, 2015 |
February 19, 2018 |
|
- Kennedy Krieger Institute
Baltimore, Maryland, United States
|
| 134 |
NCT02746445 |
Completed |
A Longitudinal Study on the Safety and Efficacy for Subjects With ASD Who Received MeRT |
|
|
Observational |
|
- Newport Brain Research Laboratory
|
Industry |
- Observational Model: Cohort
- Time Perspective: Prospective
|
- Change in Childhood Autism Rating Scale (CARS)
- Childhood Autism Rating Scale (CARS)
|
11 |
All |
6 Years to 15 Years (Child) |
NCT02746445 |
MeRT-015 |
|
April 2016 |
April 2017 |
April 2017 |
April 21, 2016 |
May 9, 2017 |
|
- Brain Treatment Center
Newport Beach, California, United States
|
| 135 |
NCT02747056 |
Recruiting |
Study of the Personal Identity in Adults With Autism Spectrum Disorder Without Intellectual Deficiency |
- Autism Spectrum Disorders
|
- Other: clinical, psychological and neuropsychological assessment
- Other: Autobiographical memories Assessment
- Other: Autobiographical memories assessment characteristics
|
Interventional |
Not Applicable |
- University Hospital, Strasbourg, France
|
Other |
- Allocation: Non-Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Basic Science
|
- The number of details in the memory (A)/The specificity of the memory (B)
- Study A and B: Autistic symptoms questionnaire 1
- Study A and B: Autistic symptoms questionnaire 2
- (and 12 more...)
|
104 |
All |
18 Years to 65 Years (Adult) |
NCT02747056 |
6282 |
TSASDI |
June 2016 |
September 2019 |
December 2019 |
April 21, 2016 |
September 11, 2017 |
|
- Hôpitaux universitaires de Strasbourg
Strasbourg, France
|
| 136 |
NCT02897687 |
Completed |
Facebook for Social Skills Training in Autism: Project Rex Connect |
|
- Behavioral: Facebook Group
- Behavioral: Book Club Group
|
Interventional |
Not Applicable |
- Medical University of South Carolina
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Improvements in social skills as assessed by Social Responsiveness Scale.
- Improvements in social skills as assessed by Social Skills Improvement System.
- Improvements in social skills as assessed by the Project Rex Parent Survey.
- Participant satisfaction as assessed by the Project Rex Connect Participant Survey.
|
12 |
All |
12 Years to 20 Years (Child, Adult) |
NCT02897687 |
Pro00021530 |
FBREX |
April 2013 |
June 2014 |
August 2016 |
September 13, 2016 |
September 13, 2016 |
|
- Medical University of South Carolina
Charleston, South Carolina, United States
|
| 137 |
NCT00725556 |
Completed |
The Development of Autistic Children Based on Mothers´Response in Autism Behavior Checklist |
|
|
Interventional |
Phase 1
Phase 2 |
- Federal University of São Paulo
|
Other |
- Allocation: Non-Randomized
- Intervention Model: Parallel Assignment
- Masking: Double (Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- To evaluate the process of development of autistic children, in a direct and indirect intervention context from mother´s response in Autism Behavior Checklist.
|
11 |
All |
3 Years to 12 Years (Child) |
NCT00725556 |
Ana Carina Tamanaha |
|
March 2006 |
March 2007 |
December 2007 |
July 30, 2008 |
August 1, 2008 |
|
- Ana Carina Tamanaha
São Paulo, Brazil
|
| 138 |
NCT01248728 |
Completed
Has Results |
Omega-3 Fatty Acids For Treatment Of Young Children With Autism (OMG) |
|
- Dietary Supplement: Omega-3 Fatty Acids
- Dietary Supplement: Placebo
|
Interventional |
Phase 2 |
- Evdokia Anagnostou
- Holland Bloorview Kids Rehabilitation Hospital
- The Hospital for Sick Children
- Anagnostou, Evdokia, M.D.
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- Change From Baseline in the Pervasive Developmental Disorder-Behavioral Inventory (PDDBI) - Autism Composite Score
- Change From Baseline in the Behaviour Assessment System for Children (BASC-2) - Externalizing Problems Composite
- Number of Participants Classified as Responders by the Clinical Global Impression - Improvement (CGI-I)
- (and 2 more...)
|
38 |
All |
2 Years to 5 Years (Child) |
NCT01248728 |
09-018 |
|
November 2010 |
December 2013 |
June 2014 |
November 25, 2010 |
May 18, 2016 |
May 18, 2016 |
- Holland Bloorview Kids Rehabilitation Hospital
Toronto, Ontario, Canada
|
| 139 |
NCT02195401 |
Completed |
The Effects of a Clean Room Sleeping Environment on Elemental and Chemical Concentrations in Children With Autism |
|
|
Observational |
|
- The Children's Institute
- Duquesne University
- Health Resources and Services Administration (HRSA)
|
Other / U.S. Fed |
- Observational Model: Cohort
- Time Perspective: Prospective
|
- Change in blood and hair elemental concentrations
- Change of xenobiotic chemical concentrations
|
10 |
All |
3 Years to 21 Years (Child, Adult) |
NCT02195401 |
09-131 |
|
May 2010 |
October 2010 |
October 2010 |
July 21, 2014 |
July 21, 2014 |
|
- The Children's Institute
Pittsburgh, Pennsylvania, United States
|
| 140 |
NCT03310775 |
Enrolling by invitation |
A Research on the Effect of Korean Version of PEERS Social Skills Training for Young Adults (PEERS-YA-K) With Autism Spectrum Disorder |
- Autism Spectrum Disorder
- Autism
|
- Behavioral: Parent-assisted social skills training program for young adult with ASD
|
Interventional |
Not Applicable |
- Seoul National University Hospital
|
Other |
- Allocation: Randomized
- Intervention Model: Sequential Assignment
- Masking: Double (Participant, Care Provider)
- Primary Purpose: Treatment
|
- Change from baseline in Autism Diagnostic Observation Schedule(ADOS) at 4 month
- Change from baseline in Test of Adolescent Social Skills Knowledge(TASSK) at 4 month
- Change from baseline in Korean Version of the Social Skills Rating System (K-SSRS) at 4 month
- (and 3 more...)
|
48 |
All |
18 Years to 35 Years (Adult) |
NCT03310775 |
B-1611-371-303 |
|
November 9, 2016 |
October 30, 2018 |
October 30, 2018 |
October 16, 2017 |
October 16, 2017 |
|
|
| 141 |
NCT01417026 |
Completed
Has Results |
Intranasal Oxytocin and Learning in Autism |
- Autism Spectrum Disorders
|
- Drug: Intranasal Oxytocin (Trade name: Syntocinon)
|
Interventional |
Phase 2 |
- Robert Schultz
- Children's Hospital of Philadelphia
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- Change From Baseline to Post-testing (After Max. 12 Days) on the Part/Whole Identity Test (LFI Skills Battery)
- Change From Baseline to Post-testing (After Max. 12 Days) on the Reading the Mind in the Eyes Test (Child Version)
- Changes From Baseline to Post-testing (After Max. 12 Days) on the "Happy Faces" Measure of Social Attention
|
36 |
Male |
12 Years to 17 Years (Child) |
NCT01417026 |
11-008241 |
|
September 2011 |
April 2015 |
April 2015 |
August 16, 2011 |
March 30, 2017 |
March 30, 2017 |
- The Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
|
| 142 |
NCT03408886 |
Recruiting |
Microbiota Transfer Therapy for Adults With Autism Spectrum Disorder (ASD) Who Have Gastrointestinal Disorders |
- Autism Spectrum Disorder
- Gastrointestinal Disorder
|
- Drug: Vancomycin
- Drug: MoviPrep
- Biological: Full Spectrum Microbiota
|
Interventional |
Phase 2 |
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- Change in Childhood Autism Rating Scale (CARS) from baseline to 10 weeks
- Change in Daily Stool Log (DSL) from baseline to 10 weeks
- Change in Social Responsiveness Scale - 2 from baseline to 10 weeks of treatment
- Change in Aberrant Behavior Checklist from baseline to 10 weeks
|
84 |
All |
18 Years to 60 Years (Adult) |
NCT03408886 |
MTT-Adults-1
Wi1XWH-16-1-0492 |
MTT-ASD |
January 4, 2018 |
October 4, 2020 |
September 1, 2021 |
January 24, 2018 |
January 24, 2018 |
|
- Arizona State University
Tempe, Arizona, United States
|
| 143 |
NCT02584972 |
Unknown † |
Postural Control During Walking and Standing Among Children With Autism Spectrum Disorder |
|
- Other: no intervention required
|
Observational |
|
- Soroka University Medical Center
|
Other |
- Observational Model: Case Control
- Time Perspective: Cross-Sectional
|
- postural stability measures
- 6 meter Narrow Path Walking Test
|
40 |
All |
6 Years to 12 Years (Child) |
NCT02584972 |
Sor 274-13 CTIL |
PCASD |
November 2015 |
October 2017 |
October 2017 |
October 23, 2015 |
November 3, 2015 |
|
- Ben-guion University of the Negev,
Beer-Sheva, Israel - Soroka University Medical Center
Beer-Sheva, Israel
|
| 144 |
NCT01333072 |
Completed |
Biomarkers in Autism of Aripiprazole and Risperidone Treatment (BAART) |
|
- Drug: Aripiprazole
- Drug: Risperidone
|
Interventional |
Phase 4 |
- Medical University of South Carolina
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Supportive Care
|
- To identify phenotypic and genetic traits that predict response to aripiprazole and risperidone in Autistic Disorder
|
82 |
All |
6 Years to 17 Years (Child) |
NCT01333072 |
R01HD062550-01A1 |
BAART |
July 2011 |
August 2015 |
August 2015 |
April 11, 2011 |
March 16, 2016 |
|
- Medical University of South Carolina
Charleston, South Carolina, United States
|
| 145 |
NCT01541033 |
Completed |
Biomarker of Children With Familial Autoimmune History |
|
|
Observational |
|
- Le Bonheur Children's Hospital
- University of Tennessee Health Science Center
|
Other |
- Observational Model: Case Control
- Time Perspective: Prospective
|
- Number of autistic participants with autoimmune markers
- Identification of neuronal protein autoimmunity
|
58 |
All |
4 Years to 17 Years (Child) |
NCT01541033 |
08-00206-XP |
|
November 2009 |
May 2016 |
August 2016 |
February 29, 2012 |
August 19, 2016 |
|
- LeBonheur Children's Hospital
Memphis, Tennessee, United States
|
| 146 |
NCT01197131 |
Active, not recruiting |
Urinary Steroid Metabolites in Autism |
- Autism
- Autism Spectrum Disorder
|
|
Observational |
|
- Intersci Research Association, Austria
|
Other |
- Observational Model: Cohort
- Time Perspective: Prospective
|
- difference in hormone formation and androgen precursors
- difference in hormone formation in gender and age
|
160 |
All |
5 Years to 15 Years (Child) |
NCT01197131 |
protocol 1.0/18/06/2010 |
|
September 2010 |
July 2011 |
March 2018 |
September 9, 2010 |
December 27, 2017 |
|
- Intersci Research Association
Leibnitz, Steiermark, Austria
|
| 147 |
NCT01914939 |
Recruiting |
A Randomized, Controlled Trial of Intranasal Oxytocin as an Adjunct to Behavioral Therapy for Autism Spectrum Disorder |
- Autism Spectrum Disorders
|
- Drug: Oxytocin
- Behavioral: Social Skills focused CBT
- Behavioral: Stress management/relaxation training
- Drug: placebo drug
|
Interventional |
Phase 2 |
- Massachusetts General Hospital
- Massachusetts Institute of Technology
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- Changes in the Autism Diagnostic Observation Schedule (ADOS)
- Clinical Global Impression Scale (CGI)
- Social Responsiveness Scale (SRS)
- (and 2 more...)
|
100 |
Male |
18 Years to 40 Years (Adult) |
NCT01914939 |
W81XWH-12-1-0543
Clinical Trial Award |
|
April 2014 |
November 2017 |
November 2017 |
August 2, 2013 |
August 29, 2017 |
|
- Massachusetts General Hospital
Boston, Massachusetts, United States - Massachusetts Institute of Technology Martinos Imaging Center
Cambridge, Massachusetts, United States
|
| 148 |
NCT01260961 |
Active, not recruiting |
Developing Treatment, Treatment Validation and Treatment Scope in the Setting of an Autism Clinical Trial |
|
- Dietary Supplement: Placebo
- Dietary Supplement: Docosahexanoic Acid
|
Interventional |
Not Applicable |
- Rutgers, The State University of New Jersey
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- Amelioration of phenotypic features of autism
- oxidative stress biomarkers
|
132 |
All |
5 Years to 17 Years (Child) |
NCT01260961 |
0220080189 |
|
November 2010 |
November 2013 |
December 2017 |
December 15, 2010 |
November 29, 2016 |
|
- Rutgers
Piscataway, New Jersey, United States
|
| 149 |
NCT01724047 |
Completed |
Autism Intervention Research Network for Behavioral Health (AIR-B II): Deployment Into Elementary Schools |
|
- Behavioral: Playground Intervention
- Behavioral: STAT Intervention
|
Interventional |
Not Applicable |
- Health Resources and Services Administration (HRSA)
- University of Rochester
- University of Pennsylvania
|
U.S. Fed / Other |
- Allocation: Randomized
- Intervention Model: Factorial Assignment
- Masking: Double (Participant, Outcomes Assessor)
- Primary Purpose: Treatment
|
- Playground Intervention: Playground Peer Engagement
- Playground Intervention: Social Network Salience
- STAT Intervention: Teacher Behaviors and Student's Engagement in the Classrooms
- (and 11 more...)
|
250 |
All |
4 Years and older (Child, Adult, Senior) |
NCT01724047 |
12-001120 |
AIR-B II |
November 2012 |
June 2014 |
June 2014 |
November 9, 2012 |
September 25, 2014 |
|
- UCLA Semel Institute
Los Angeles, California, United States - University of Rochester Medical Center
Rochester, New York, United States - UPENN Map Center for Mental Health Policy and Services Research
Philadelphia, Pennsylvania, United States
|
| 150 |
NCT01502488 |
Withdrawn |
Adipose Derived Stem Cell Therapy for Autism |
|
- Procedure: Fat Harvesting and Stem Cell Injection
|
Interventional |
Phase 1
Phase 2 |
- Ageless Regenerative Institute
- Instituto de Medicina Regenerativa, S.A. de C.V.
|
Industry |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Improvement in the Childhood Autism Rating Scale，CARS
- Improvement in the Clinical Global Impression Scale, CGI
- Improvement in the Aberrant Behavior Checklist, ABC
|
0 |
All |
3 Years to 12 Years (Child) |
NCT01502488 |
ADI-AT-001 |
|
October 2016 |
November 2017 |
January 2018 |
December 30, 2011 |
July 21, 2017 |
|
- Ageless Regenerative Institute LLC
Aventura, Florida, United States
|
Create an RSS feed from your search for:
Download the search results for: